"Medicare covers Ozempic now." You've probably seen that headline. It's half true, and the wrong half is the half that matters. Starting July 1, 2026, a new temporary program called the Medicare GLP-1 Bridge lets some people on Medicare get certain weight-loss drugs for $50 a month. But it's narrow, it's gated, and it runs out December 31, 2027. Here's the honest, plain-English version: who actually qualifies, why a diabetes diagnosis can push you off the program, which drugs are covered, and the $50 catch. Every figure traces back to CMS and Medicare.gov.
Why is the "Medicare covers Ozempic now" headline only half true?
For years, regular Medicare drug plans were barred by law from covering a drug used only for weight loss. The Bridge doesn't repeal that. It doesn't fold these drugs into your normal Part D plan. It sits outside your plan entirely, a separate, temporary lane the government built to test what happens when access is widened, and to collect data before deciding anything permanent. So the accurate version of the headline is narrower: for a limited time, a specific group of people can get a short list of weight-loss drugs, through a special side door, for $50. That's the truth, and the truth is what keeps you from being disappointed at the pharmacy counter.
What is the GLP-1 Bridge?
Here's the mental model to hang the whole thing on. The Medicare GLP-1 Bridge is a short-term test program, and the government's own word for it is a demonstration. It lets eligible people with Medicare drug coverage get certain GLP-1 medications, for weight loss, at a flat $50 a month. Three words to hold onto: temporary, weight-only, and gated.
- Temporary. It runs from July 1, 2026, and is scheduled to end December 31, 2027, a little over a year and a half. Then, unless something changes, it's gone.
- Weight-only. It's strictly for weight loss and weight maintenance, not for diabetes, not for anything else.
- Gated. There's a real list of conditions you have to clear to get in.
Why does it matter that it sits outside your Part D plan?
This one structural fact drives almost every surprise in this program. The Bridge doesn't run through your Part D plan. A single central processor handles the prior authorization, claims, and pharmacy payment, and your Part D plan carries no risk and doesn't even have to opt in. That's convenient in one way, but it means the $50 you pay lives in a completely separate bucket from the rest of your drug spending. Keep that in mind. It comes back at the end, and it's the most misunderstood part of the whole deal.
Do you need Part D drug coverage first?
Meet Nancy. She's 68, she saw the headline, and she's thrilled, so she picks up the phone to sign herself up, treating it like flipping a switch. The person on the other end asks one question she wasn't ready for: which Medicare drug plan are you on? Nancy is on Original Medicare, Part A and Part B, and she never added a separate drug plan. And right there she learns the very first rule the hard way: the Bridge only works if you already have Medicare drug coverage, meaning Part D. No drug plan, no Bridge, no matter how well you'd meet every other rule.
What counts as "drug coverage" is broader than people think. Any of these gets that first question a yes: a standalone Part D prescription drug plan; a Medicare Advantage plan that includes drug coverage (an MA-PD, HMO or PPO); a Special Needs Plan (SNP); an employer or union group plan that runs through Medicare (an EGWP); or the limited LI NET program. What doesn't count: Part A and Part B alone, with no drug plan attached. That was Nancy, and if you aren't sure which bucket you're in, that's the very first thing to pin down.
What is the BMI gate?
Meet Gary, 62. His BMI is about 33, and he has prediabetes. He'd heard the "magic number" was 35, so he does the math, lands at 33, and writes himself off: not me, I'm under the line. He's about to leave $50 medicine on the table over a number he half-remembered, because there isn't one door on weight. There are three, and here's the principle that makes them click: the lower your weight, the more your health has to justify the medicine.
- BMI 35 or higher. Qualifies on weight alone.
- BMI 30 to 34.99. Qualifies plus at least one listed condition: HFpEF (a specific kind of heart failure), uncontrolled high blood pressure, chronic kidney disease at stage 3a or worse, prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease. This is Gary's door: prediabetes is right there on the list. He isn't out. He's in.
- BMI 27 to 29.99. The door still opens, but the list of conditions that count gets shorter: prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease.
One rule holds at every level, and your doctor has to confirm it: that you're using the medication as part of a real diet-and-exercise plan. The drug is meant to be part of the plan, not the whole plan.
The twist most people get backwards: a diagnosis can push you OFF the Bridge
Meet Sharon, 65. Her BMI is around 36, comfortably over the top line, and she has type 2 diabetes. She assumes she's first in line. She's turned away. Why? The Bridge is only for weight loss, and diabetes is a medical diagnosis her regular Part D plan may already be allowed to cover a GLP-1 for, the ordinary way. The Bridge was built as a last resort for people with no other covered path, and Sharon has one. It isn't only diabetes: moderate-to-severe sleep apnea and fatty liver disease (MASH) work the same way. A diagnosis your own plan can act on sends you to that plan, not the Bridge. If that's you, ask your plan first.
Which drugs are covered?
When your doctor writes the prescription, it can come from a short, specific list:
- Foundayo, the tablet form.
- Wegovy, covered as either an injection or a tablet.
- Zepbound, but only in one specific form: the KwikPen. Not the single-dose vials, not the single-dose pens. If you and your doctor lean toward Zepbound, the word that has to land on that prescription is KwikPen, or the coverage doesn't follow the pen.
Notice that Ozempic isn't on this list, which is exactly why the "Medicare covers Ozempic now" headline is so misleading.
The $50 catch: it doesn't count toward your Part D cap
Meet Walter, 70. He qualifies clean and is thrilled about his $50 a month. But Walter is a planner. He also takes several other prescriptions through his regular Part D plan, and he knows that once his out-of-pocket drug spending passes a yearly ceiling, he's capped and pays $0 for the rest of the year. So he pencils it in: $50 a month, twelve months, $600, surely that marches me toward my cap faster. It doesn't. Because the Bridge lives outside Part D, not one dollar of that $50 counts toward your deductible or your out-of-pocket cap. The same fact wears four hats: the $50 never appears on your Part D Explanation of Benefits or Medicare Summary Notice, Extra Help and the low-income subsidy can't lower it, and it can't be spread out through the Medicare Prescription Payment Plan. It's a genuinely good price. It just won't play with any of your other Part D math. Source: CMS, the Medicare GLP-1 Bridge.
Is $50 still a good deal?
Usually, yes. Don't hear "catch" and walk away thinking the whole thing is a trap. For a lot of people, Gary for instance, the Bridge is straightforwardly a great deal. If Gary was going to pay many hundreds a month out of pocket, or simply go without, then $50 a month is a real gift, and the fact that it doesn't touch his Part D cap is almost beside the point, because that drug was never going to be covered by his Part D plan anyway. The neighbor who needs to slow down is Walter, the one mentally filing the $50 under his regular drug spending. It isn't "good deal versus bad deal." It's: know exactly which bucket the $50 lives in, and plan the rest of your year around the truth.
When does the program end?
This is the line that gets buried at the bottom of every article, and it may be the most important one: the program has an expiration date. It runs from July 1, 2026, and is currently scheduled to end December 31, 2027, a little over a year and a half. It's a test, and the government is gathering data before deciding whether to build anything permanent. So if you're a genuine fit, the calendar itself is part of the decision. The reassuring half: once your doctor completes the approval, the prior authorization, that approval is good all the way through December 31, 2027, refills and dose changes included, as long as you don't switch to a different GLP-1. The window to start is finite. The coverage, once you're in, is steady.
How do you actually get it?
Back to Nancy, once she's sorted out her coverage question. Her path is the whole thing on one screen:
- Confirm you actually have Part D drug coverage. That's the exact thing that tripped Nancy up.
- Check your eligibility at the official page, Medicare.gov/glp1bridge, or by calling 1-800-MEDICARE (1-800-633-4227). Use the government's own page, not a third-party site selling something around the edges.
- Talk to your provider. If you're eligible, they send the prescription for a covered GLP-1 to your pharmacy and complete the prior authorization when it's requested.
- At the pharmacy, have your Medicare Number or the last four digits of your Social Security number ready. That's normal, not a red flag.
- Watch for the confirmation letter under the Medicare GLP-1 Bridge, and keep it. That letter is your proof you're in.
Free "Do I qualify?" checklist
The Part D rule, the three-door BMI gate, the covered drugs, and the $50 catch: the whole GLP-1 Bridge on one page, so you can walk it yourself.
Get the free guides→Which of these four is you?
Line the four up one last time, because they're the whole point:
- Nancy, excited, but no drug plan. Her real first move isn't the Bridge. It's understanding her Part D enrollment. Without that first door, nothing else matters.
- Gary, who meets the BMI gate, has no disqualifying diagnosis, and has a doctor willing to build a real plan. He may be exactly who this was designed for. Worth a serious conversation this month, while the window is open.
- Sharon, carrying a diagnosis like type 2 diabetes, sleep apnea, or fatty liver disease. She shouldn't assume the Bridge. She should ask whether her own Part D plan already opens a door.
- Walter, thrilled about the $50. He should get it in writing which bucket it lives in and plan the rest of his year's drug spending around the fact that it stands alone.
Not one of those answers is the headline's "everybody gets Ozempic for fifty bucks." The job was never to find the answer. It was to find your answer.
Clear the noise: real program, real limits
This is a real, in-effect 2026 program, not "act before midnight" pressure, but it's temporary, narrow, and gated. The details are from CMS and Medicare.gov and can change, so confirm your own situation at Medicare.gov/glp1bridge or by calling 1-800-MEDICARE, and talk to your doctor about whether one of these drugs is right for you before you act on anything here.
Related
Go deeper on Medicare: Medicare enrollment at 65: windows & penalties, IRMAA, the Medicare income surcharge, and the July 2026 money changes for retirees.
Sources
• CMS: CMS Launches Medicare GLP-1 Bridge, Expanding Access to GLP-1 Medications (press release)
• CMS: Medicare GLP-1 Bridge program & FAQ hub
• Medicare: Weight loss drugs / GLP-1 Bridge (who qualifies)
• Medicare: GLP-1 Bridge fact sheet (PDF)
• Check your eligibility: Medicare.gov/glp1bridge · 1-800-MEDICARE (1-800-633-4227)
Not financial or medical advice. This article is educational only — it is not personal financial advice, and it is not medical, tax, or legal advice. Jeffrey is not a doctor. Whether a GLP-1 is right for you is a conversation for you and your physician, and you should check your own eligibility at Medicare.gov/glp1bridge before acting on anything here.
Watch this on the channel
Same question, in full.
Common questions
Does Medicare cover Ozempic now?
Not the way the headlines suggest. Regular Medicare drug plans are still barred from covering a drug used only for weight loss. What changed is a separate, temporary program called the Medicare GLP-1 Bridge, which runs July 1, 2026 through December 31, 2027 and lets some eligible people get certain weight-loss GLP-1 drugs for $50 a month through a special side lane, not through their normal Part D plan. Ozempic itself is not on the Bridge's covered list. The covered drugs are Foundayo, Wegovy, and Zepbound (KwikPen form only).
Who qualifies for the Medicare GLP-1 Bridge?
You need Medicare drug coverage (Part D: a standalone plan, a Medicare Advantage plan with drug coverage, an SNP, an EGWP, or LI NET), you must be 18 or older, and you must clear a BMI gate with your doctor certifying you are using the drug as part of a diet-and-exercise plan. Having Part A and Part B alone, with no drug plan, does not qualify you.
What is the BMI gate for the $50 GLP-1 Bridge?
There are three doors, and the lower your weight, the more your health has to justify the medicine. A BMI of 35 or higher qualifies on weight alone. A BMI of 30 to 34.99 qualifies with at least one listed condition (HFpEF heart failure, uncontrolled high blood pressure, chronic kidney disease stage 3a or worse, prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease). A BMI of 27 to 29.99 qualifies with a shorter list: prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease.
Which weight-loss drugs are covered by the Bridge?
Three: Foundayo (tablet), Wegovy (injection or tablet), and Zepbound, but Zepbound is only covered in the KwikPen form. The single-dose Zepbound vials and single-dose pens are not covered.
When does the Medicare GLP-1 Bridge end?
It is temporary. The program runs from July 1, 2026 and is scheduled to end December 31, 2027, a little over a year and a half. It is a government demonstration built to test wider access and gather data. Once your doctor completes the prior authorization, that approval is good through December 31, 2027, including refills and dose changes, as long as you do not switch to a different GLP-1.
What if I have type 2 diabetes, sleep apnea, or fatty liver disease?
This is the counterintuitive catch. Type 2 diabetes, moderate-to-severe sleep apnea, and fatty liver disease (MASH) are medical diagnoses your own Part D plan may already be allowed to cover a GLP-1 for. The Bridge was built as a last resort for people with no other covered path, so a qualifying diagnosis routes you to your own plan instead of the Bridge. Ask your plan first.